Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 7 studies | 26% ± 7% | |
non-classical monocyte | 5 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of RASGRP4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1378.84 | 578 / 578 | 71% | 1.87 | 815 / 1155 |
breast | 90% | 249.63 | 413 / 459 | 70% | 1.51 | 781 / 1118 |
stomach | 79% | 187.56 | 282 / 359 | 61% | 1.42 | 175 / 286 |
bladder | 100% | 294.81 | 21 / 21 | 39% | 0.92 | 198 / 504 |
intestine | 94% | 241.97 | 912 / 966 | 44% | 0.98 | 230 / 527 |
esophagus | 80% | 204.70 | 1162 / 1445 | 52% | 1.08 | 96 / 183 |
kidney | 53% | 110.79 | 47 / 89 | 75% | 2.26 | 673 / 901 |
adrenal gland | 93% | 241.78 | 240 / 258 | 28% | 0.52 | 64 / 230 |
brain | 31% | 49.22 | 818 / 2642 | 90% | 3.56 | 631 / 705 |
uterus | 83% | 159.97 | 141 / 170 | 35% | 0.68 | 160 / 459 |
skin | 57% | 101.74 | 1026 / 1809 | 59% | 1.50 | 277 / 472 |
prostate | 82% | 165.69 | 202 / 245 | 32% | 0.48 | 161 / 502 |
ovary | 37% | 61.24 | 66 / 180 | 67% | 1.82 | 288 / 430 |
spleen | 100% | 3998.44 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 571.67 | 1196 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 13429.29 | 862 / 929 | 0% | 0 | 0 / 0 |
thymus | 53% | 78.56 | 345 / 653 | 40% | 0.76 | 240 / 605 |
pancreas | 24% | 36.40 | 78 / 328 | 68% | 1.75 | 121 / 178 |
liver | 58% | 111.09 | 132 / 226 | 20% | 0.37 | 83 / 406 |
blood vessel | 73% | 196.23 | 973 / 1335 | 0% | 0 | 0 / 0 |
heart | 68% | 125.94 | 589 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 3.94 | 18 / 29 |
tonsil | 0% | 0 | 0 / 0 | 49% | 0.84 | 22 / 45 |
muscle | 40% | 54.58 | 323 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 0.47 | 24 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140367 | Biological process | antibacterial innate immune response |
GO_0002717 | Biological process | positive regulation of natural killer cell mediated immunity |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0030099 | Biological process | myeloid cell differentiation |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0019992 | Molecular function | diacylglycerol binding |
Gene name | RASGRP4 |
Protein name | RAS guanyl releasing protein 4 variant 9 RAS guanyl-releasing protein 4 |
Synonyms | |
Description | FUNCTION: Functions as a cation- and diacylglycerol (DAG)-regulated nucleotide exchange factor activating Ras through the exchange of bound GDP for GTP. May function in mast cells differentiation. . |
Accessions | ENST00000615439.5 [Q8TDF6-1] Q8TDF6 ENST00000586305.5 [Q8TDF6-2] ENST00000454404.6 [Q8TDF6-8] ENST00000589358.5 [Q8TDF6-1] C0LTP6 ENST00000587753.5 [Q8TDF6-9] ENST00000617966.4 [Q8TDF6-7] ENST00000622174.4 [Q8TDF6-6] ENST00000614135.4 [Q8TDF6-5] ENST00000587738.2 [Q8TDF6-1] ENST00000589474.5 [Q8TDF6-2] |